Capricor Therapeutics
CAPR
#7610
Rank
HK$3.75 B
Marketcap
HK$64.65
Share price
13.81%
Change (1 day)
37.04%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026HK$93.79 M-40.48%
2025HK$0.15 B154.62%
2024HK$61.89 M1584.06%
2023HK$3.67 M24.67%
2022HK$2.94 M-49.93%
2021HK$5.88 M-88.57%
2020HK$51.49 M573.14%
2019HK$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
HK$0.18 BHK$0.40 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$4.15 MHK$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
HK$16.82 MHK$0.27 B๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$2.91 MHK$12.62 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
HK$2.44 MHK$3.76 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/AHK$4.49 M๐Ÿ‡บ๐Ÿ‡ธ USA